We spoke to Dr Timir Paul (Cardiovascular Research, Quillen College of Medicine, East Tennessee State University, Johnson City, TN, USA) about the update in guidelines for embolic protection devices and coronary saphenous vein bypass grafts, as well as his observations on the relative effectiveness of drug-eluting stents compared with bare-metal stents.
Speaker’s Disclosures: Timir Paul has nothing to declare in relation to this video interview.
1. Recently, the role of embolic protection devices’ coronary saphenous vein bypass grafts has been re-examined in guidelines; what has changed and what advice would you provide to physicians on how to incorporate this guidance into practice? (0:04)
2. What are your observations on the recent studies assessing relative effectiveness of drug-eluting stents compared with bare-metal stents in patients undergoing saphenous vein graft interventions? (1:57)
3. What are your key highlights from your presentations at this year’s C3 congress? (3:45)
touchCARDIO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
Filmed in partnership with C3 at the 2019 annual meeting in Orlando, Florida, June 2019.
Share this Video
Related Videos In Interventional Cardiology
Zsolt Piroth, TCT 2022: The value of post-PCI FFR and intravascular imaging for cardiovascular failure, a FAME 3 substudy
This FAME 3 substudy aimed to define the value of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) and intravascular imaging for cardiovascular failure. In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the substudy of the FAME 3 trial and the implications for clinical practice. […]
Zsolt Piroth, TCT 2022: The value of measuring post-PCI FFR in patients with coronary artery disease
The impact of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) has been assessed in patients with coronary artery disease (CAD). In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the prognostic value for measuring post-PCI FFR and intravascular imaging in CAD. Click here for part […]
Ole De Backer, TCT 2022: FEops HEARTguide™ Computational Modelling for left atrial appendage (LAA) closure, the PREDICT LAA trial
The PREDICT LAA trial aimed to examine whether cardiac computed tomography- based FEops HEARTguide™ computational modelling would benefit clinical outcomes when planning for left atrial appendage (LAA) closure. In this touchCARDIO interview, we speak with Dr Ole De Backer (Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark) to discuss the PREDICT LAA trial and the next steps. […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!